[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 8 of about 8
1. Oller AR, Kirkpatrick DT, Radovsky A, Bates HK: Inhalation carcinogenicity study with nickel metal powder in Wistar rats. Toxicol Appl Pharmacol; 2008 Dec 1;233(2):262-75
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Epidemiological studies of nickel refinery workers have demonstrated an association between increased respiratory cancer risk and exposure to certain nickel compounds (later confirmed in animal studies).
  • No increased incidence of neoplasm of the respiratory tract was observed.
  • Adrenal gland pheochromocytomas (benign and malignant) in males and combined cortical adenomas/carcinomas in females were induced in a dose-dependent manner by the nickel metal exposure.
  • The incidence of cortical tumors among 0.4 mg Ni/m(3) females, although statistically higher compared to the concurrent controls, falls within the historical control range; therefore, in the present study, this tumor is of uncertain relationship to nickel metal exposure.
  • The lack of respiratory tumors in the present animal study is consistent with the findings of the epidemiological studies.
  • [MeSH-major] Carcinogenicity Tests / methods. Carcinogens / toxicity. Inhalation Exposure / adverse effects. Lung / drug effects. Nickel / toxicity
  • [MeSH-minor] Adrenal Cortex Neoplasms / chemically induced. Adrenal Gland Neoplasms / chemically induced. Adrenocortical Adenoma / chemically induced. Adrenocortical Carcinoma / chemically induced. Animals. Dose-Response Relationship, Drug. Female. Male. Models, Animal. Occupational Exposure / adverse effects. Pheochromocytoma / chemically induced. Powders. Rats. Rats, Wistar. Respiratory Tract Neoplasms / epidemiology. Respiratory Tract Neoplasms / etiology. Sex Factors

  • Hazardous Substances Data Bank. NICKEL, ELEMENTAL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18822311.001).
  • [ISSN] 1096-0333
  • [Journal-full-title] Toxicology and applied pharmacology
  • [ISO-abbreviation] Toxicol. Appl. Pharmacol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Carcinogens; 0 / Powders; 7OV03QG267 / Nickel
  •  go-up   go-down


2. Armbruster C: Novel treatments for recurrent respiratory papillomatosis. Expert Opin Investig Drugs; 2002 Aug;11(8):1139-48
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Novel treatments for recurrent respiratory papillomatosis.
  • Recurrent respiratory papillomatosis is a rare but often severe disease.
  • Although benign in histology, epithelial proliferations may result in progressive hoarseness, stridor, obstruction of the airway and respiratory distress.
  • Many adjuvant therapies have been investigated but no single treatment modality proved to be effective in eradicating recurrent respiratory papillomatosis.
  • In contrast to HIV, cytomegalovirus and hepatitis B pharmaceutical research has been less successful with human papilloma virus vaccines for a variety of reasons.
  • This review focuses on the current status of recurrent respiratory papillomatosis and on future directions of prevention and therapy.
  • [MeSH-major] Antiviral Agents / therapeutic use. Neoplasm Recurrence, Local / prevention & control. Papilloma / drug therapy. Papillomaviridae / drug effects. Respiratory Tract Neoplasms / drug therapy
  • [MeSH-minor] Humans. Laser Therapy. Papillomavirus Infections / drug therapy. Papillomavirus Infections / surgery. Papillomavirus Infections / virology. Tumor Virus Infections / drug therapy. Tumor Virus Infections / surgery. Tumor Virus Infections / virology

  • Genetic Alliance. consumer health - Recurrent respiratory papillomatosis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 12150707.001).
  • [ISSN] 1354-3784
  • [Journal-full-title] Expert opinion on investigational drugs
  • [ISO-abbreviation] Expert Opin Investig Drugs
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antiviral Agents
  • [Number-of-references] 85
  •  go-up   go-down


3. Kim TK, Kim KH, Kim CH, Shin SW, Kwon JY, Kim HK, Baik SW: Percutaneous vertebroplasty and facet joint block. J Korean Med Sci; 2005 Dec;20(6):1023-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • It is surprising that about 24% of patients with benign osteoporotic vertebral fracture die within a year from respiratory infection and urinary tract infection because of coughing and voiding difficulties, depending on the sites of compression fractures.
  • We reviewed 500 patients on whom percutaneous vertebroplasty (PVP) was performed, at 612 levels in terms of patient selection, operation technique, medication, and clinical outcomes during the follow-up course for 2 yr study period.
  • The mean changes of numeric rating scale scores, Oswestry Disability Index except sex life, and Karnofsky performance status were -72.00, -83.50 and +60.62% in the osteoporosis group and -51.89, -45.02, and 69.03% in the tumor group.

  • MedlinePlus Health Information. consumer health - Spine Injuries and Disorders.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Neuroradiology. 2001 May;43(5):409-12 [11396748.001]
  • [Cites] Med Sci Monit. 2001 Sep-Oct;7(5):1108-17 [11535963.001]
  • [Cites] J Clin Endocrinol Metab. 2002 Mar;87(3):985-92 [11889149.001]
  • [Cites] Drugs Aging. 2002;19(1):43-78 [11929326.001]
  • [Cites] Cancer. 1986 Jul 1;58(1):178-82 [2423224.001]
  • [Cites] Pain. 2003 Oct;105(3):387-92 [14527699.001]
  • [Cites] BMJ. 1996 May 18;312(7041):1254-9 [8634613.001]
  • [Cites] J Vasc Interv Radiol. 2002 Nov;13(11):1135-8 [12427813.001]
  • [Cites] J Vasc Interv Radiol. 2003 Jul;14(7):827-31 [12847189.001]
  • [Cites] Spine (Phila Pa 1976). 2003 Jul 15;28(14):1540-7; discussion 1548 [12865841.001]
  • [Cites] Radiology. 2003 Oct;229(1):27-36 [14519867.001]
  • [Cites] Am J Med. 1986 Sep;81(3):381-6 [2428242.001]
  • (PMID = 16361816.001).
  • [ISSN] 1011-8934
  • [Journal-full-title] Journal of Korean medical science
  • [ISO-abbreviation] J. Korean Med. Sci.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Korea (South)
  • [Chemical-registry-number] 0 / Bone Cements
  • [Other-IDs] NLM/ PMC2779303
  •  go-up   go-down


Advertisement
4. Nakamura H, Taniguchi Y, Miwa K, Adachi Y, Fujioka S, Haruki T: The use of Blake drains following general thoracic surgery: is it an acceptable option? Interact Cardiovasc Thorac Surg; 2009 Jan;8(1):58-61
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The use of Blake drains following general thoracic surgery: is it an acceptable option?
  • As a method of chest drainage, we analyzed the extended utility of silastic flexible drains (Blake drains, Ethicon, Inc., Somerville, NJ) for general thoracic surgery.
  • In 420 cases of general thoracic surgery, Blake drains were used.
  • The treated diseases for which Blake drains were used comprised 181 cases of primary lung cancer, 44 cases of metastatic lung tumor, 57 cases of benign lung disease, 32 cases of mediastinal tumor, 6 cases of myasthenia gravis, 76 cases of spontaneous pneumothorax, 14 cases of chest wall and/or pleural tumor, 6 cases of empyema, and 4 cases of diaphragmatic disease.
  • Blake drains functioned efficiently in 3 cases of re-operation for postoperative bleeding, 2 cases of adhesion therapy with drugs for persistent air leaks, and 1 case of re-operation for chylothorax.
  • The use of Blake drains for general thoracic surgery is considered to be an acceptable option, and it is necessary to proceed with further investigations of larger numbers of cases.
  • [MeSH-major] Chest Tubes. Drainage / instrumentation. Respiratory Tract Diseases / surgery. Thoracic Surgical Procedures. Thoracostomy / instrumentation

  • Hazardous Substances Data Bank. POLYDIMETHYLSILOXANES .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18835856.001).
  • [ISSN] 1569-9285
  • [Journal-full-title] Interactive cardiovascular and thoracic surgery
  • [ISO-abbreviation] Interact Cardiovasc Thorac Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Dimethylpolysiloxanes; 63148-62-9 / baysilon
  •  go-up   go-down


5. Derkay CS, Wiatrak B: Recurrent respiratory papillomatosis: a review. Laryngoscope; 2008 Jul;118(7):1236-47
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Recurrent respiratory papillomatosis: a review.
  • Recurrent respiratory papillomatosis (RRP), which is caused by human papillomavirus types 6 and 11, is the most common benign neoplasm of the larynx among children and the second most frequent cause of childhood hoarseness.
  • Less common presenting symptoms include chronic cough, recurrent pneumonia, failure to thrive, dyspnea, dysphagia, or acute respiratory distress, especially in infants with an upper respiratory tract infection.
  • Adjuvant therapies that have been investigated include dietary supplements, control of extra-esophageal reflux disease, potent antiviral and chemotherapeutic agents, and photodynamic therapies; although several have shown promise, none to date has "cured" RRP, and some may have serious side effects.
  • Because RRP, although histologically benign, is so difficult to control and can cause severe morbidity and death, better therapies are needed.
  • The potential for a quadrivalent human papilloma vaccine is being explored to reduce the incidence of this disease.
  • [MeSH-major] Hoarseness / etiology. Laryngeal Neoplasms / diagnosis. Neoplasm Recurrence, Local / diagnosis. Papilloma / diagnosis. Respiratory Sounds / etiology
  • [MeSH-minor] Adult. Airway Obstruction / etiology. Child. Combined Modality Therapy. Humans. Laryngoscopy. Larynx / pathology. Larynx / surgery. Neoplasm Staging. Tumor Burden


6. Kim M, Chung YH, Johnston RN: Reovirus and tumor oncolysis. J Microbiol; 2007 Jun;45(3):187-92
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Reovirus and tumor oncolysis.
  • REOviruses (Respiratory Enteric Orphan viruses) are ubiquitous, non-enveloped viruses containing 10 segments of double-stranded RNA (dsRNA) as their genome.
  • They are common isolates of the respiratory and gastrointestinal tract of humans but are not associated with severe disease and are therefore considered relatively benign.
  • This observation has led to the use of the virus in clinical trials as an anti-cancer agent against oncogenic tumors.
  • Reovirus is, however, not entirely benign to immunocompromised animal models.
  • Reovirus causes so-called "black feet syndrome" in immunodeficient mice and can also harm neonatal animals.
  • Because cancer patients often undergo immunosuppression due to heavy chemo/radiation-treatments or advanced tumor progression, this pathogenic response may be a hurdle in virus-based anticancer therapies.
  • However, a genetically attenuated reovirus variant derived from persistent reovirus infection of cells in vitro is able to exert potent anti-tumor activity with significantly reduced viral pathogenesis in immunocompromised animals.
  • [MeSH-minor] Animals. Humans. Mice

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17618222.001).
  • [ISSN] 1225-8873
  • [Journal-full-title] Journal of microbiology (Seoul, Korea)
  • [ISO-abbreviation] J. Microbiol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] Korea (South)
  • [Number-of-references] 62
  •  go-up   go-down


7. Makowska W: [The role of human papillomaviruses (HPV) in upper respiratory tract diseases]. Otolaryngol Pol; 2004;58(2):305-10
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [The role of human papillomaviruses (HPV) in upper respiratory tract diseases].
  • High-risk papillomaviruses (HPVs) are etiologic agents for anogenital tract cancers and have been detected in head and neck squamous cell carcinomas.
  • The HPV infection in benign head and neck diseases were also presented.
  • [MeSH-major] Papillomaviridae. Papillomavirus Infections / complications. Respiratory Tract Infections / virology. Respiratory Tract Neoplasms / virology. Tumor Virus Infections / complications

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15307476.001).
  • [ISSN] 0030-6657
  • [Journal-full-title] Otolaryngologia polska = The Polish otolaryngology
  • [ISO-abbreviation] Otolaryngol Pol
  • [Language] pol
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] Poland
  • [Number-of-references] 30
  •  go-up   go-down


8. Mullin LS, Kennedy GL Jr, Wood CK: Nasal tumors in rats following long-term inhalation exposure to 1,4-dichlorobutene-2 (DCB). Drug Chem Toxicol; 2000 Aug;23(3):403-17
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • This study was conducted to elucidate the time- and dose-response relationships of long-term, low-level 1,4-dichlorobutene-2 (DCB) inhalation exposure to nasal tumor induction in rats.
  • Tissues from the respiratory tract, lymph nodes, and brain were evaluated microscopically.
  • A statistically significant increase in benign nasal tumors (adenomas) occurred in rats from all three DCB-exposed groups.
  • The adenomas occurred in the respiratory region of the nasal cavity and were first observed in the 1.0 ppm group at study month 10.
  • [MeSH-minor] Adenocarcinoma / chemically induced. Adenocarcinoma / complications. Adenocarcinoma / pathology. Administration, Inhalation. Animals. Body Weight / drug effects. Carcinogenicity Tests. Carcinosarcoma / chemically induced. Carcinosarcoma / pathology. Corynebacterium Infections / pathology. Dose-Response Relationship, Drug. Inhalation Exposure. Lung Diseases / complications. Lung Diseases / microbiology. Lung Diseases / pathology. Male. Nasal Cavity / drug effects. Nasal Cavity / pathology. Organ Size / drug effects. Precancerous Conditions / chemically induced. Precancerous Conditions / complications. Precancerous Conditions / pathology. Rats. Rhabdomyosarcoma / chemically induced. Rhabdomyosarcoma / pathology. Time Factors

  • MedlinePlus Health Information. consumer health - Nasal Cancer.
  • Hazardous Substances Data Bank. 1,4-DICHLORO-TRANS-2-BUTENE .
  • Hazardous Substances Data Bank. 1,4-DICHLORO-CIS-2-BUTENE .
  • Hazardous Substances Data Bank. 1,4-DICHLORO-2-BUTENE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 10959544.001).
  • [ISSN] 0148-0545
  • [Journal-full-title] Drug and chemical toxicology
  • [ISO-abbreviation] Drug Chem Toxicol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] UNITED STATES
  • [Chemical-registry-number] 0 / Carcinogens; 0 / Hydrocarbons, Chlorinated; 764-41-0 / 1,4-dichloro-2-butene
  •  go-up   go-down






Advertisement